Becton Dickinson And Company (BDX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Becton Dickinson And Company  (NYSE: BDX)


Becton Dickinson And's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Becton Dickinson And's ROI in the third quarter of 2026?
Becton Dickinson And Company achieved a return on average invested assets (ROI) of 2.22 % in its third quarter of 2026, which is below Becton Dickinson And's average return on investment, which stands at 8.62%.

ROI fell compared to the second quarter of 2026, despite the net income growth of % from the second quarter of 2026.

Within the Healthcare sector 138 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1977 to 1998.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM -4.47 % -3.5 % -0.61 % 1.63 % 2.52 %
Y / Y Net Income Change TTM -40.63 % -24.03 % 47.65 % 89.18 % 225.46 %
Investment (TTM) in Millions 41,327 39,944 44,080 44,096 43,987
Return On Investment (TTM) 2.22 % 2.64 % 3.99 % 3.8 % 3.57 %
BDX's Overall Ranking # 1998 # 1977 # 1173 # 1321 # 1335
Seq. Investment Change TTM -1.55 % -2.22 % -0.39 % -0.38 % -0.54 %
Seq. Net Income Change TTM -17.31 % -35.23 % 4.71 % 5.87 % 5.81 %
Net Income (TTM) in Millions 941 1,138 1,757 1,678 1,585

BDX Company Profile >> Back to BDX Roi Comparisons >> See Annual BDX Return On Investment



Return On Investment BDX's Ranking
Within: No.
Industry # 47
Sector # 139
Overall # 1998

Return On Investment Statistics
High Average Low
20.6 %
8.62 %
0.12 %
(Sep. 30, 2010)   (Mar 31 2018)







Financial Statements
Becton Dickinson And's III. Quarter Investments $ 41,327 Millions BDX's Balance sheet
Becton Dickinson And's III. Quarter Income $ 377 Millions Quarterly BDX's Income Statement
BDX's Income by Division See BDX's Income by Division


BDX Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 44,080 44,772 41,557 40,070 47,240
Y / Y Investment Growth -1.55 % 7.74 % 3.71 % -15.18 % -1.94 %
Net Income in Millions 1,678 1,705 1,484 1,779 2,092
Y / Y Net Income Growth -1.58 % 14.89 % -16.58 % -14.96 % 139.36 %
Annual Return On Investment 3.81 % 3.81 % 3.57 % 4.44 % 4.43 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BDX's Competitors
Subscribers only: Roi for Becton Dickinson And's Suppliers
Subscribers only: Return On Investment for BDX's Customers

Other Ratios
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Statistics
BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.